Abstract
When 7721 human hepatocarcinoma cells were treated with 100nm phorbol-12-myristate-13-acetate (PMA), the activity ofN-acetylglucosaminyltransferase V(GnT-V) in the cells varied in accordance with the activity of membranous protein kinase C (PKC), but not with that of cytosolic PKC. Quercetin, a non-specific inhibitor of Ser/Thr protein kinase, andd-sphingosine and staurosporine, two specific inhibitors of PKC, blocked the activation of membranous PKC and GnT-V by PMA. Among the three inhibitors, quercetin was least effective. The inhibitory rates of quercetin and staurosporine toward membranous PKC and GnT V were proportional to the concentrations of the two inhibitors. The activities of GnT V and membranous protein kinase A (PKA) were also induced in parallel by dibutyryl cAMP (db-cAMP) and this induction was blocked by a specific PKA inhibitor. When cell free preparations of 7721 cells and human kidney were treated with alkaline phosphatase (ALP) to remove the phosphate groups, the GnT V activities were decreased. These results suggest that GnT V may be activated by membranous PKC or PKA, indirectly or directly, via phosphorylation of Ser/Thr residues.
Similar content being viewed by others
Abbreviations
- UDP:
-
uridine diphospho-
- GnT:
-
N-acetylglucosaminyltransferase
- GlcNAc Gn:
-
N-acetylglucosamine
- M:
-
mannose
- PMA:
-
phorbol-12-myristate-13-acetate
- PKC:
-
protein kinase C
- PKA:
-
protein kinase A
- cAMP:
-
adenosine 3′, 5′-cyclic monophosphate
- db-cAMP:
-
dibutyryl cAMP
- TPK:
-
tyrosine protein kinase
- MES:
-
2-[N-morpholino]ethanesulfonic acid
- DTT:
-
dithiothreitol
- PMSF:
-
phenylmethylsulfonyl fluoride
- EDTA:
-
ethylene diamine tetraacetic acid
- EGTA:
-
glycol-bis-(α-aminoethyl) etherN,N,N′,N′-tetraacetic acid
- PA:
-
2-aminopyridine
- ALP:
-
alkaline phosphatase
- C2C2 :
-
GlcNAcβ1-2 Manα1-6(GlcNAcβ1-2Manα1-3)ManβR
- C2,4C2 :
-
GlcNAcβ1-2Manα1-6(GlcNAcβ1-4[GlcNAcβ1-2]Manα1-3)ManβR
- C2C2,6 :
-
GlcNAcβ1-6[GlcNAcβ1-2]Manα1-6(GlcNAcβ1-2Manα1-3)ManβR
- C2,4C2,6 :
-
GlcNAcβ1-6[GlcNAcβ1-2]Manα1-6(GlcNAcβ1-4[GlcNAcβ1-2]Manα1-3)ManβR where R=1-4GlcNAcβ1-4GlcNAcAsnX
- Gn2M3Gn2-PA:
-
C2C2 where R=1-4GlcNAcβ1-4GlcNAc-PA
- Gn3M3Gn2-PA:
-
C2C2,6 where R=1-4GlcNAcβ1-4GlcNAc-PA
References
Brockhausen I, Narasimhan S, Schachter H (1988)Biochimie 70: 1521–33.
Nishikawa A, Gu JG, Fujii S, Taniguchi N (1990)Biochim Biophys Acta 1035: 313–18.
Gu JX, Meng XW, Ren JX, Tang H, Chen HL (1993)Chinese Biochem J 9: 653–58.
Dennis JW, Lafarté S (1989)Cancer Res 49: 945–50.
Yamashita K, Tachibana Y, Ohkura T, Kobata A (1985)J Biol Chem 260: 3963–69.
Pierce M, Arango J (1986)J Biol Chem 261: 10772–77.
Yousefi S, Higgins E, Daoling Z, Pollex-Kruger A, Hindsgaul O, Dennis JW (1991)J Biol Chem 266: 1772–82.
Santer UV, Gilbert F, Glick MC (1984)Cancer Res 44: 3730–35.
Dennis JW, Kosh K, Bryce DM, Breitman ML (1989)Oncogene 4: 853–60.
Easton EW, Bolscher JG, Van den Eijnden DH (1991)J Biol Chem 266: 21674–80.
Shoreibah MG, Hindsgaul O, Pierce M (1992)J Biol Chem 207: 2920–27.
Shoreibah MG, Perng G-S, Adler B, Weinstein J, Basu R, Cupples K, Wen D, Browne JK, Buckhaults P, Fregien N, Pierce M (1993)J Biol Chem 268: 15381–85.
Dong SC, Ren JX, Yang XP, Gu JX, Chen HL (1994)Acta Biochim Biophys Sinica 26: 536–40.
Nishizuka Y (1986)Science 233: 305–12.
Ai ZW, Zha XL, Liu Y, Chen HL (1990)J Tumor Mark Oncol 5: 59–70.
Feng YM, Sun JL, Tong CX, Zhang XT, Zhang YS (1987)Acta Biochim Biophys Sinica 19: 322–27.
Hase S, Ibuki T, Ikenaka T (1984)J Biochem 95: 197–203.
Kikkawa U, Minakuchi R, Takai Y, Nishizuka Y (1983)Methods Enzymol 99: 288–98.
Yu BZ, Standaert M, Arnold T, Hernandez H, Watson J, Ways K, Cooper DR, Farese RV (1992)Endocrinology 130: 3345–55.
Tamura S, Kikuchi K (1978)Biochim Biophys Acta 524: 349–54.
Tang H, Chen HL (1994)Acta Acad Med Shanghai 21: 176–81.
Kong SK, Wang GH (1987)J Biol Chem 262: 2597–603.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951)J Biol Chem 193: 265–71.
Bradford M (1976)Anal Biochem 72: 248–54.
Darbon J-M, Issaandov M, Delassus F, Bayard F (1986)Biochem Biophys Res Commun 137: 1159–66.
Merrill AH, Stevens VL (1989)Biochim Biophys Acta 1010: 131–39.
Hamamoto Y, Matsuyama T, Yamamoto N, Kobayashi N (1990)Cancer Res 50: 5287–90.
Hagiwara M, Inoue S, Tanaka T, Nunoki K, Ito M, Hidaka H (1988)Biochem Pharmacol 37: 2987–92.
Cheng HC, Kemp BE, Pearson RB, Smith AJ, Misconi L, Walsh DA (1986)J Biol Chem 261: 489–92.
Huang J, Kim Y, Matthews HR (1992)J Biol Chem 267: 15511–15.
Momoi T, Shinmoto M, Kasuya J, Senoo H, Suzuki Y (1986)J Biol Chem 261: 16270–73.
Scheideler MA, Dawson G (1986)J Neurochem 46: 1639–43.
Bruce AB, Donald EA, Vincent JK (1990)Biochem Biophys Res Commun 171: 196–99.
Kuo F, Anderson RGG, Wise BC, Mackelova L, Salomonsson I, Brackett NL, Katoh N, Shoji M, Wrenn RW (1980)Proc Nat Acad Sci USA 77: 7039–43.
Kemp BE, Pearson RB (1990)Trends Biochem Sci 15: 342–46.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ju, TZ., Chen, HL., Gu, JX. et al. Regulation ofN-acetylglucosaminyltransferase V by protein kinases. Glycoconjugate J 12, 767–772 (1995). https://doi.org/10.1007/BF00731237
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00731237